---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-270422"
form_type: "8-K/A"
ticker: "CDXS"
cik: "0001200375"
company_name: "CODEXIS, INC."
filed_at: "2023-11-03T23:59:59+00:00"
generated_at: "2026-06-08T22:03:55.009438+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Codexis revises restructuring costs; records $9.2M asset impairment on facility

## Summary
- Workforce reduction of ~25% completed by Sept 30, 2023; actual severance costs $3.1M vs. expected $2.9M.
- Non-cash goodwill impairment of $0.8M from discontinuing Biotherapeutics programs.
- Non-cash asset impairment of $9.2M related to San Carlos facility previously assigned to Vaxcyte.
- Operations streamlined by exiting Biotherapeutics development and consolidating to headquarters.

## SEC filing metadata
- accession: 0001193125-23-270422
- form_type: 8-K/A
- ticker: CDXS
- cik: 0001200375
- company_name: CODEXIS, INC.
- filed_at: 2023-11-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.05, 2.06
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1200375/000119312523270422/0001193125-23-270422-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1200375/000119312523270422/d490820d8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-270422
- JSON: https://secwatch.observer/filing/0001193125-23-270422.json
- Plain text: https://secwatch.observer/filing/0001193125-23-270422.txt

## Key facts
- Restructurings & Charges
  CODEXIS, INC. announced a restructuring with charges of approximately $2.9 million affecting the Company (approximately 25%).
  - Type: restructuring
  - Charge: approximately $2.9 million
  - Affected area: the Company
  - Headcount: approximately 25%
  source text: the Company expected to record an expense of approximately $2.9 million in connection with the payment of post-employment benefits to employees impacted by the workforce reduction, as well as the payment of other expenses such as related tax costs
  evidence_url: https://www.sec.gov/Archives/edgar/data/1200375/000119312523270422/0001193125-23-270422-index.htm
- Restructurings & Charges
  CODEXIS, INC. announced a impairment with charges of approximately $0.8 million affecting Biotherapeutics.
  - Type: impairment
  - Charge: approximately $0.8 million
  - Affected area: Biotherapeutics
  source text: the Company recorded one-time, non-cash charges, including approximately $0.8 million related to goodwill impairment from the decision to discontinue investment in its Biotherapeutics programs
  evidence_url: https://www.sec.gov/Archives/edgar/data/1200375/000119312523270422/0001193125-23-270422-index.htm
- Restructurings & Charges
  CODEXIS, INC. announced a impairment with charges of approximately $9.2 million affecting San Carlos Facility.
  - Type: impairment
  - Charge: approximately $9.2 million
  - Affected area: San Carlos Facility
  source text: approximately $9.2 million related to the impairment and write-down of assets related to the San Carlos Facility
  evidence_url: https://www.sec.gov/Archives/edgar/data/1200375/000119312523270422/0001193125-23-270422-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.